News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-12-05 EST			5-day change	1st Jan Change
309.60 ^DKK	+1.24%		-2.33%	-50.40%

11:10am	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT
09:24am	Sector Update: Health Care Stocks Rise Pre-Bell Friday	MT

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	11:10am	MT
Sector Update: Health Care Stocks Rise Pre-Bell Friday	09:24am	MT
Berenberg Says Novo Nordisk Deserves Higher Valuation, Shares Rise - BN	06:12am	FW
Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide	05:58am	MT
India's Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact	04:53am	RE
NOVO NORDISK : Berenberg gives a Buy rating	02:49am	ZD
Novo Nordisk Presents New Topline Results from Their Evoke and Evoke+ Phase 3 Trials of Semaglutide	12-04	CI
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs -- 2nd Update	12-04	DJ
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs -- Update	12-04	DJ
Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide	12-04	MT
Novo Nordisk Eyes Launching Ozempic in India This Month	12-04	MT
Novo Nordisk gears up for Ozempic launch in India, sources say	12-04	RE
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs	12-04	DJ
NOVO NORDISK : UBS reaffirms its Neutral rating	12-04	ZD
Bråse's Fund Sells All Shares in Novo Nordisk	12-04	FW
Germany's cartel office says it approved acquisition of Akero Therapeutics by Novo Nordisk	12-04	RE
Germany's cartel office says it approved acquisition of Akero Therapeutics by Novo Nordisk	12-04	RE
UBS Lowers Price Target for Novo Nordisk to 295 Danish Kroner, Reiterates Neutral Rating	12-04	FW
Novo Nordisk Open to Further Development of Ozempic for Alzheimer's Despite Failed Trials	12-04	FW
Denmark raises growth outlook despite Novo Nordisk woes	12-04	RE
Denmark Investigates Whether Novo Nordisk Should Pay Wegovy-Related Eye Disease Compensation - DR	12-04	FW
Novo Nordisk to Launch Ozempic in India in Coming Weeks - Reuters	12-04	FW
Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment	12-03	RE
Novo Nordisk gears up for December Ozempic launch in India, sources say	12-03	RE
Akero Therapeutics stockholders approve acquisition by Novo Nordisk	12-03	RE